SEC Form 4 · accession 0001246360-16-007221
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Giannini
Director
Period of report
Nov 21, 2016
Accepted (ET)
Nov 22, 2016 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 21, 2016 | S | 6,449 | $25.96 | D | 63,193 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents the weighted average price for shares sold in multiple transactions at prices ranging from $25.82 to $26.12, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.